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LETTERS TO THE EDITOR 
Guidelines for Training in Adult 
Cardiovascular Medicine 
We read with great interest he "Guidelines for Training in Adult 
Cardiovascular Medicine: Core Cardiology Training Symposium 
(COCATS)" (1). This important document clearly is the result of 
careful thought and much deliberation on the part of the many 
contributors egarding the difficult issue of optimal training time that 
cardiology fellows spend in the various areas of cardiovascular medi- 
cine. In this era of a rapidly expanding knowledge base, increasing 
scrutiny by regulators and increasing debate as to the proper goals of 
fellowship training--given the ascendancy of managed care and 
resulting shrinkage of employment opportunities for new cardiolo- 
gists--a redefinition of appropriate raining in cardiovascular medicine 
is important. 
As stated in the document's introduction, "The guidelines recom- 
mended in this document differ from those suggested by the Accred- 
itation Council for Graduate Medical Education (ACGME)." Because 
training programs must adhere to ACGME requirements for accred- 
itation, it is instructive to review how the American College of 
Cardiology (ACC) guidelines and the ACGME standards compare 
(1,2). Although organized somewhat differently, the basic require- 
ments of each are quite similar and not in substantial conflict with each 
other. The ACGME requirements for specified time assigned to 
various ervices total 18 months, whereas the ACC guidelines for time 
assigned to basic training services total 22 months. The ACC guide- 
lines are more specifically detailed than the ACGME requirements, 
but the additional 4 months of specifically recommended training 
activity of the former easily supplement the requirements of the latter. 
A discrepancy does arise, however, in that these basic time allotments 
are considered full clinical training for a general cardiologist by the 
ACGME, whereas the ACC guidelines only consider them a founda- 
tion on which to build competency in specific areas (such as cardiac 
catheterization r echocardiography) b  further training. 
An additional conflict arises between the American Board of 
Internal Medicine's implied requirement for a year of research expe- 
rience (3) and the proposed ACC recommendations for time spent in 
a "specialized area of concentration." For example, under the ACC 
guidelines, fellows wishing to "perform independent diagnostic cardiac 
catheterization a d angiography" should experience an additional 8
months in the catheterization laboratory, which of necessity would 
need to be done during the third "research" year. This would clearly at 
least dilute and at most defeat he goal of offering cardiology trainees 
a year of research experience. 
Further complicating decisions regarding training requirements is 
the changing role of subspecialists a our health care system evolves 
(4). Will the cardiologist be primarily an intensivist, proceduralist, 
educator or researcher, ather than a general cardiovascular consult- 
ant? 
We believe that serious discussions should be held between repre- 
sentatives of the ACGME, the ACC and the American Board of 
Internal Medicine (ABIM) to address this conflict. Should the de- 
mands of a need for more thorough clinical training preempt part of 
the year of research experience? Are the Level 2 training recommen- 
dations of the ACC document (allowing for independent practice in a 
specific area of cardiology) excessive? Should, indeed, the ACC seek to 
accredit cardiology training programs by its own standards (or seek to 
have its standards adopted by me ACGME and ABIM)? Should 
training requirements encourage program flexibility in seeking to meet 
the uncertain role of cardiologists? Leaving these issues unsettled will 
only invite confusion at a time when our specialty can ill afford it. 
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Giant Cell Myocarditis Study Group 
This letter serves as our announcement of the formation of the 
Multicenter Giant Cell Myocarditis Study Group. Giant cell myocar- 
ditis is a rare and frequently fatal disorder that has been described in 
only case reports and two small series (1). The goal of this project is to 
gather a data base of patients with the diagnosis of idiopathic giant cell 
myocarditis from U.S. and international cardiovascular centers. Many 
questions are unresolved about the natural history and treatment of 
this rare disease. They can only be answered by assembling multicenter 
patient data. 
The data collection and analysis will be organized at the University 
of California at San Diego. If you know of any patients with this 
diagnosis, we would greatly appreciate your participation. In return for 
our use of anonymous patient data, you and your medical center will be 
named in any publications that come from the data base, and there 
may be opportunities for authorship as well. 
If you have patients with the diagnosis of idiopathic giant cell 
myocarditis, please contact us at the following address. We will send a 
detailed questionnaire and further information. 
Thank you in advance for any information you provide. 
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